chrM-8340-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The ENST00000387421.1(MT-TK):n.46G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely pathogenic (★★★).
Frequency
Mitomap GenBank:
Absent
Consequence
MT-TK
ENST00000387421.1 non_coding_transcript_exon
ENST00000387421.1 non_coding_transcript_exon
Scores
Mitotip
Uncertain
Clinical Significance
Myopathy+-Exercise-Intolerance+-CPEO-like-/childhood-epilepsy-with-SNHL-&-eye-disease
Conservation
PhyloP100: 1.38
Genes affected
MT-TK (HGNC:7489): (mitochondrially encoded tRNA lysine)
MT-ATP8 (HGNC:7415): (mitochondrially encoded ATP synthase 8) Contributes to proton-transporting ATP synthase activity, rotational mechanism. Involved in mitochondrial ATP synthesis coupled proton transport. Part of mitochondrial proton-transporting ATP synthase complex. Implicated in multiple sclerosis and urinary bladder cancer. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
No frequency data in Mitomap. Probably very rare.
PP3
Mitotip and hmtvar scores support pathogenic criterium.
PP5
Variant M-8340-G-A is Pathogenic according to our data. Variant chrM-8340-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 986424.Status of the report is reviewed_by_expert_panel, 3 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRNK | TRNK.1 use as main transcript | n.46G>A | non_coding_transcript_exon_variant | 1/1 | ||||
ATP8 | ATP8.1 use as main transcript | upstream_gene_variant | YP_003024030.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MT-TK | ENST00000387421.1 | n.46G>A | non_coding_transcript_exon_variant | 1/1 | ||||||
MT-ATP8 | ENST00000361851.1 | upstream_gene_variant | ENSP00000355265 | P1 |
Frequencies
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
We have no GnomAD4 genomes data on this position. Probably position not covered by the project.
Mitomap
Myopathy+-Exercise-Intolerance+-CPEO-like-/childhood-epilepsy-with-SNHL-&-eye-disease
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: reviewed by expert panel
LINK: link
Submissions by phenotype
Mitochondrial disease Pathogenic:1
Likely pathogenic, reviewed by expert panel | curation | ClinGen Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel, ClinGen | May 22, 2023 | The m.8340G>A variant in MT-TK has been reported in five unrelated individuals with features of primary mitochondrial disease (PS4_moderate; PMIDs: 24161205, 29501485, 28729369, 36999085, 34969639). Affected individuals were variably affected and had myopathy, exercise intolerance, muscle weakness, and chronic progressive external ophthalmoplegia (CPEO). Additional features seen include sensorineural hearing loss, retinal dystrophy, cataracts, migraines, epilepsy, microcephaly, and poor growth, and one individual was reported to have congenital heart disease and urinary tract anomalies. There are at least three de novo occurrences reported in the literature (PM6; PMIDs: 29501485, 28729369, 24161205). This variant is absent in the GenBank dataset, Helix dataset, and gnomAD v3.1.2 (PM2_supporting). The computational predictor MitoTIP suggests this variant is pathogenic (65th percentile) and HmtVAR predicts it to be pathogenic score of 0.4 (PP3). Single fiber testing showed higher levels of the variant in COX-deficient fibers (93.1% ± 0.26%, N=17) than in COX-positive fibers (29.5% ± 8.97, N=16), p<0.0001 (PS3_supporting, PMID: 28729369). In summary, this variant meets criteria to be classified as likely pathogenic for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on May 22, 2023. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS4_moderate, PM6, PM2_supporting, PP3, PS3_supporting. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mitotip
Uncertain
Hmtvar
Pathogenic
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.